Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 |
filingDate |
2009-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f475a7564af7bed510987b2751e9e49c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a936ee6ce23c56066f2b04fc84cd053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70cc15256a5dce3c4b9eb0e81735f51a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_519e5649bcdefcda16b30191967e0d57 |
publicationDate |
2019-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BR-PI0912604-A2 |
titleOfInvention |
quinolinylmethylimidazoles as therapeutic agents |
abstract |
"quinolinylmethylimidazoles as therapeutic agents". The present invention relates to methods for treating a disorder associated with selective subtype modulation of alpha adrenergic receptors 2b and 2c. Such methods may be performed, for example, by administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of at least one compound having structure (1): It also relates to compositions and medicaments related thereto. . |
priorityDate |
2008-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |